SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes

The inflammatory response plays a central role in the complications of congenital pulmonary airway malformations (CPAM) and severe coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the transcriptional changes induced by SARS-CoV-2 exposure in pediatric MSCs derived from pedi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Andrea Valeri, Luigi Chiricosta, Agnese Gugliandolo, Mara Biasin, Maria Antonietta Avanzini, Valeria Calcaterra, Gioia Cappelletti, Stephana Carelli, Gian Vincenzo Zuccotti, Serena Silvestro, Emanuela Mazzon, Gloria Pelizzo
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/ecfe1e1cbdbb4ae296289ef6959c7e1b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ecfe1e1cbdbb4ae296289ef6959c7e1b
record_format dspace
spelling oai:doaj.org-article:ecfe1e1cbdbb4ae296289ef6959c7e1b2021-11-11T17:15:20ZSARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes10.3390/ijms2221118141422-00671661-6596https://doaj.org/article/ecfe1e1cbdbb4ae296289ef6959c7e1b2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11814https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067The inflammatory response plays a central role in the complications of congenital pulmonary airway malformations (CPAM) and severe coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the transcriptional changes induced by SARS-CoV-2 exposure in pediatric MSCs derived from pediatric lung (MSCs-lung) and CPAM tissues (MSCs-CPAM) in order to elucidate potential pathways involved in SARS-CoV-2 infection in a condition of exacerbated inflammatory response. MSCs-lung and MSCs-CPAM do not express angiotensin-converting enzyme 2 (<i>ACE2</i>) and transmembrane serine protease 2 (<i>TRMPSS2</i>). SARS-CoV-2 appears to be unable to replicate in MSCs-CPAM and MSCs-lung. MSCs-lung and MSCs-CPAM maintained the expression of stemness markers MSCs-lung show an inflammatory response (<i>IL6</i>, <i>IL1B</i>, <i>CXCL8</i>, and <i>CXCL10</i>), and the activation of Notch3 non-canonical pathway; this route appears silent in MSCs-CPAM, and cytokine genes expression is reduced. Decreased value of p21 in MSCs-lung suggested no cell cycle block, and cells did not undergo apoptosis. MSCs-lung appears to increase genes associated with immunomodulatory function but could contribute to inflammation, while MSCs-CPAM keeps stable or reduce the immunomodulatory receptors expression, but they also reduce their cytokines expression. These data indicated that, independently from their perilesional or cystic origin, the MSCs populations already present in a patient affected with CPAM are not permissive for SARS-CoV-2 entry, and they will not spread the disease in case of infection. Moreover, these MSCs will not undergo apoptosis when they come in contact with SARS-CoV-2; on the contrary, they maintain their staminality profile.Andrea ValeriLuigi ChiricostaAgnese GugliandoloMara BiasinMaria Antonietta AvanziniValeria CalcaterraGioia CappellettiStephana CarelliGian Vincenzo ZuccottiSerena SilvestroEmanuela MazzonGloria PelizzoMDPI AGarticlemesenchymal stromal cellcongenital pulmonary airway malformationsSARS-CoV-2transcriptomic analysisBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11814, p 11814 (2021)
institution DOAJ
collection DOAJ
language EN
topic mesenchymal stromal cell
congenital pulmonary airway malformations
SARS-CoV-2
transcriptomic analysis
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle mesenchymal stromal cell
congenital pulmonary airway malformations
SARS-CoV-2
transcriptomic analysis
Biology (General)
QH301-705.5
Chemistry
QD1-999
Andrea Valeri
Luigi Chiricosta
Agnese Gugliandolo
Mara Biasin
Maria Antonietta Avanzini
Valeria Calcaterra
Gioia Cappelletti
Stephana Carelli
Gian Vincenzo Zuccotti
Serena Silvestro
Emanuela Mazzon
Gloria Pelizzo
SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes
description The inflammatory response plays a central role in the complications of congenital pulmonary airway malformations (CPAM) and severe coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate the transcriptional changes induced by SARS-CoV-2 exposure in pediatric MSCs derived from pediatric lung (MSCs-lung) and CPAM tissues (MSCs-CPAM) in order to elucidate potential pathways involved in SARS-CoV-2 infection in a condition of exacerbated inflammatory response. MSCs-lung and MSCs-CPAM do not express angiotensin-converting enzyme 2 (<i>ACE2</i>) and transmembrane serine protease 2 (<i>TRMPSS2</i>). SARS-CoV-2 appears to be unable to replicate in MSCs-CPAM and MSCs-lung. MSCs-lung and MSCs-CPAM maintained the expression of stemness markers MSCs-lung show an inflammatory response (<i>IL6</i>, <i>IL1B</i>, <i>CXCL8</i>, and <i>CXCL10</i>), and the activation of Notch3 non-canonical pathway; this route appears silent in MSCs-CPAM, and cytokine genes expression is reduced. Decreased value of p21 in MSCs-lung suggested no cell cycle block, and cells did not undergo apoptosis. MSCs-lung appears to increase genes associated with immunomodulatory function but could contribute to inflammation, while MSCs-CPAM keeps stable or reduce the immunomodulatory receptors expression, but they also reduce their cytokines expression. These data indicated that, independently from their perilesional or cystic origin, the MSCs populations already present in a patient affected with CPAM are not permissive for SARS-CoV-2 entry, and they will not spread the disease in case of infection. Moreover, these MSCs will not undergo apoptosis when they come in contact with SARS-CoV-2; on the contrary, they maintain their staminality profile.
format article
author Andrea Valeri
Luigi Chiricosta
Agnese Gugliandolo
Mara Biasin
Maria Antonietta Avanzini
Valeria Calcaterra
Gioia Cappelletti
Stephana Carelli
Gian Vincenzo Zuccotti
Serena Silvestro
Emanuela Mazzon
Gloria Pelizzo
author_facet Andrea Valeri
Luigi Chiricosta
Agnese Gugliandolo
Mara Biasin
Maria Antonietta Avanzini
Valeria Calcaterra
Gioia Cappelletti
Stephana Carelli
Gian Vincenzo Zuccotti
Serena Silvestro
Emanuela Mazzon
Gloria Pelizzo
author_sort Andrea Valeri
title SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes
title_short SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes
title_full SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes
title_fullStr SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes
title_full_unstemmed SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes
title_sort sars-cov-2 exposed mesenchymal stromal cell from congenital pulmonary airway malformations: transcriptomic analysis and the expression of immunomodulatory genes
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/ecfe1e1cbdbb4ae296289ef6959c7e1b
work_keys_str_mv AT andreavaleri sarscov2exposedmesenchymalstromalcellfromcongenitalpulmonaryairwaymalformationstranscriptomicanalysisandtheexpressionofimmunomodulatorygenes
AT luigichiricosta sarscov2exposedmesenchymalstromalcellfromcongenitalpulmonaryairwaymalformationstranscriptomicanalysisandtheexpressionofimmunomodulatorygenes
AT agnesegugliandolo sarscov2exposedmesenchymalstromalcellfromcongenitalpulmonaryairwaymalformationstranscriptomicanalysisandtheexpressionofimmunomodulatorygenes
AT marabiasin sarscov2exposedmesenchymalstromalcellfromcongenitalpulmonaryairwaymalformationstranscriptomicanalysisandtheexpressionofimmunomodulatorygenes
AT mariaantoniettaavanzini sarscov2exposedmesenchymalstromalcellfromcongenitalpulmonaryairwaymalformationstranscriptomicanalysisandtheexpressionofimmunomodulatorygenes
AT valeriacalcaterra sarscov2exposedmesenchymalstromalcellfromcongenitalpulmonaryairwaymalformationstranscriptomicanalysisandtheexpressionofimmunomodulatorygenes
AT gioiacappelletti sarscov2exposedmesenchymalstromalcellfromcongenitalpulmonaryairwaymalformationstranscriptomicanalysisandtheexpressionofimmunomodulatorygenes
AT stephanacarelli sarscov2exposedmesenchymalstromalcellfromcongenitalpulmonaryairwaymalformationstranscriptomicanalysisandtheexpressionofimmunomodulatorygenes
AT gianvincenzozuccotti sarscov2exposedmesenchymalstromalcellfromcongenitalpulmonaryairwaymalformationstranscriptomicanalysisandtheexpressionofimmunomodulatorygenes
AT serenasilvestro sarscov2exposedmesenchymalstromalcellfromcongenitalpulmonaryairwaymalformationstranscriptomicanalysisandtheexpressionofimmunomodulatorygenes
AT emanuelamazzon sarscov2exposedmesenchymalstromalcellfromcongenitalpulmonaryairwaymalformationstranscriptomicanalysisandtheexpressionofimmunomodulatorygenes
AT gloriapelizzo sarscov2exposedmesenchymalstromalcellfromcongenitalpulmonaryairwaymalformationstranscriptomicanalysisandtheexpressionofimmunomodulatorygenes
_version_ 1718432153929252864